Invo Bioscience Inc Expected To Post A Loss Of 24 Cents A Share: Earnings Preview

INVO Fertility

12/08/2022 23:16

* INVO Bioscience Inc  INVO.OQ   INVO.O  is expected to show
a
rise in quarterly revenue when it reports  results on August
15. 
    * The Lakewood Ranch Florida-based  company is expected to
report 
a 59.4% increase in revenue to $331.5 thousand from $208
thousand a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for INVO Bioscience Inc
is
for a loss of 24 cents per share. For the same quarter last
year, the company reported a loss of 17 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for INVO
Bioscience
Inc is $2.25​, above​ its last closing price of $1.07. ​​​

This summary was machine generated August 12 at 22:16 GMT.  All
figures in US dollars  unless otherwise stated